340B Hospitals Prescribe Part D Drugs to a Much Higher Share of Vulnerable Populations, Says Hospital-Backed Report

A hospital-funded study found 340B hospitals prescribe a higher share of Medicare Part D drugs to a higher share of vulnerable patients.
Medicare Part D beneficiaries who received retail and specialty drugs from prescribers at 340B disproportionate share hospitals (DSH) were more [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Teva Adds 40th Drug to Contract Pharmacy Restriction Policy

Teva added a biosimilar of AbbVie's blockbuster Humira to its list of products included in its 340B contract pharmacy restrictions.
Teva Pharmaceuticals recently added the 40th drug to the list of medications included in its contract pharmacy policy restrictions for [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Breaking News

Appeals Court Approves Drugmakers’ Federal 340B Contract Pharmacy Restrictions But Leaves Open Possibility of Enforcement Against Stricter Policies

A federal appeals court decided that the 340B statute does not prohibit all types of restrictions on 340B contract pharmacy use.
A federal appeals court today decided that the 340B statute does not prohibit drugmakers from placing conditions on the distribution [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Minnesota Legislature Clears Contract Pharmacy Access Bill But Enforcement Measures Dropped At Last Moment

The Minnesota legislature passed a bill from state Rep. Dave Lislegard (D) to bar 340B drugmaker contract pharmacy restrictions in the state.
Shortly before adjourning, the Minnesota legislature cleared and sent to the governor legislation to bar 340B contract pharmacy access restrictions [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Hospitals Should Consider Internal Pharmacies, Selective Contracting, Says Consulting Group

Executives at a healthcare financial consulting group recommended 340B hospitals consider using in-house pharmacies.
Hospitals in the 340B program should respond to increasing drugmaker contract pharmacy restrictions by opening their own pharmacies or selectively [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Virginia Governor Vetoes 340B Contract Pharmacy Access Law that Nearly Unanimously Passed State Legislature

Virginia Gov. Glenn Youngkin (R) vetoed 340B contract pharmacy access legislation after the state senate rejected his proposed amendment.
Virginia Gov. Glenn Youngkin (R) late Friday vetoed a bill that would have prohibited drugmaker contract pharmacy restrictions on grantee [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Maryland Is Sixth State to Enact 340B Contract Pharmacy Access Law

Maryland Gov. Wes Moore (right) will make Maryland the sixth state to prohibit drugmaker 340B contract pharmacy restrictions when he signs legislation today.
Maryland Gov. Wes Moore (D) this morning is signing legislation to make Maryland the sixth state to prohibit drugmaker 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Sales Increased 17% to $124B in 2023, Drug Industry Consulting Firm Finds 

Analysts from IQVIA found that 340B wholesale acquisition cost sales increased by 17% from 2022 to 2023.
The 340B program continued to expand in 2023, exceeding $124 billion in wholesale acquisition cost (WAC) sales—up from $107 billion [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Draft Senate Bill Would Pay Hospitals to Stockpile Certain Generic Drugs if They Forgo 340B Discounts, Meet New Contracting Requirements

Sen. Mike Crapo (R-Idaho), ranking member of the Senate Finance Committee, said a bipartisan draft bill would "take meaningful strides toward mitigating and preventing prescription drug shortages."
A new Senate draft drug shortages bill would offer bonus payments to hospitals that stockpile certain generic drugs and agree [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

2024 Provider Audits Begin with No Adverse Findings

Federal auditors recently reported no adverse findings in their first fiscal year 2024 340B audit of a pharmaceutical manufacturer.
The first fiscal year 2024 340B provider audit reports included no adverse findings for 19 organizations. The May 8 audit [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live